Reference interval determination for N-terminal-B-type natriuretic peptide (NT-proBNP): A study in blood donors

被引:56
作者
Hess, G [1 ]
Runkel, S
Zdunek, D
Hitzler, WE
机构
[1] Roche Diagnost GMBH, Mannheim, Germany
[2] Johannes Gutenberg Univ Mainz Klinikum, Mainz, Germany
关键词
N-terminal-pro-B-type natriuretic peptide (NT-proBNP); natriuretic peptides (NP); cardiac function; creatinine clearance; glomerular filtration rate (GFR); hemoglobin (Hb);
D O I
10.1016/j.cccn.2005.04.031
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 [基础医学];
摘要
We assessed reference values in a group of apparently healthy blood donors. A total of 1980 blood donors was recruited and tested for the presence of NT-proBNP using a newly developed electrochemiluminescence immunoassay (ECLIA) method. NT-proBNP clustered in all blood donors below the age of 50 years and an upper limit of normal (ULN) was found to be 84 pg/ml for males and 146 pg/ml for females. Mean NT-proBNP values increased with increasing age which was due to an increasing number of individuals exceeding the ULN. Age- and gender-appropriate NT-proBNP levels decreased with increasing hemoglobin levels. Hemoglobin but not creatinine levels influenced the NT-proBNP concentration in this cohort. The upper limit of normal can be used in clinical studies to further assess groups of diseased individuals to define clinical cutoffs. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:187 / 193
页数:7
相关论文
共 21 条
[1]
Anemia and its relationship to clinical outcome in heart failure [J].
Anand, I ;
McMurray, JJV ;
Whitmore, J ;
Warren, M ;
Pham, A ;
McCamish, MA ;
Burton, PBJ .
CIRCULATION, 2004, 110 (02) :149-154
[2]
Evaluation of N-terminal pro-B type natriuretic peptide analysis on the Elecsys™ 1010 and 2010 analysers [J].
Barnes, S ;
Collinson, PO ;
Galasko, G ;
Lahiri, A ;
Senior, R .
ANNALS OF CLINICAL BIOCHEMISTRY, 2004, 41 :459-463
[3]
PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[4]
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey [J].
Coresh, J ;
Astor, BC ;
Greene, T ;
Eknoyan, G ;
Levey, AS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (01) :1-12
[5]
Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction [J].
Davidson, NC ;
Naas, AA ;
Hanson, JK ;
Kennedy, NSJ ;
Coutie, WJ ;
Struthers, AD .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (10) :828-831
[6]
Erler K, 1998, WIEN KLIN WOCHENSCHR, V110, P5
[7]
Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria [J].
Gæde, P ;
Hildebrandt, P ;
Hess, G ;
Parving, HH ;
Pedersen, O .
DIABETOLOGIA, 2005, 48 (01) :156-163
[8]
Essential biochemistry and physiology of (NT-pro)BNP [J].
Hall, C .
EUROPEAN JOURNAL OF HEART FAILURE, 2004, 6 (03) :257-260
[9]
N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease [J].
Kragelund, C ;
Gronning, B ;
Kober, L ;
Hildebrandt, P ;
Steffensen, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (07) :666-675
[10]
Levin ER, 1998, NEW ENGL J MED, V339, P321